A NEW STANDARD OF CARE
While gene expression testing adds significantly to the information provided by tumor grading, it can take up to six weeks to complete and costs more than $4,000. And because it’s used primarily with excisional specimens, it requires significant time and labor of pathology. Even then, gene expression testing still may rely on the subjective tumor grading in its risk score and the limited reporting features can lead to clinical ambiguity.
Talk to Us
Traditional tumor grading in breast cancer can be subjective, resulting in a high percentage of patients being classified with Intermediate/Grade 2 tumors even though many are low risk. As a result, patients must wait 2-6 weeks for costly gene expression test results, ultimately delaying vital care planning.
65%
Intra-observer variations in grading results***
56%
of Grade 3 tumors are low risk**
22%
of Grade 2 tumors are high risk**
78%
of Grade 2 tumors are low risk**
*Sparano, New England Journal of Medicine. 2018
**Based on a retrospective longitudinal study of more than 2,000 cancer cases. Fernandez, G., Prastawa, M., Madduri, A.S. et al. Breast Cancer Research 2022’.
***Paik, New England Journal of Medicine, 2004
.avif)
LEARN MORE, FASTER.
One diagnostic H&E-stained slide is all that is needed for PreciseBreast® testing. OncoIntelligenceTM identifies recurrence risk with accuracy and reliability.
Using PreciseBreastTM as well as visual pathologic analysis delivers benefits for patients, physicians, and payors.
.svg)
Data to drive precise analysis of recurrence risk
Faster results lessen anxiety for patients
.svg)
Lower overall testing and treatment costs
Availability to 100% of eligible patients
our process
PreciseBreast is designed specifically to improve the multidisciplinary team’s workflow, providing a complement to pathologic tumor grading.
Screening / Detection
Biopsy & Diagnosis
Resection
Tumor Grading
Tumor Staging
Gene-Expression Testing
Care Planning
The results of slow or unavailable gene-expression testing can impact patients and their anxiety levels during a critical time in their lives. These are their stories of how PreciseBreast might have made a difference.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare
A patient’s individual health benefits will determine insurance coverage for the PreciseBreast test. PreciseDx will do all we can to ensure the test is affordable to patients. If you are interested in inquiring about your individual health benefits, please contact your health plan directly. The PreciseBreast billing code is CPT 0220U.
There are differences among health insurance programs that determine an individual patient’s covered services, co-insurance, co-pay and deductible. It is difficult to determine what an individual’s out-of-pocket cost might be for the PreciseBreast test until the entire billing and appeals process is complete.
If your health plan denies your claim for any reason, PreciseDx will appeal the claim on your behalf. We will work diligently to get the claim paid through our exhaustive appeal process. You may receive one or more Explanation of Benefits (EOB)(s) during this process. An EOB is NOT A BILL.
Please review the information on our Patient Assistance Program (PAP) to determine whether you qualify for a reduced out-of-pocket cost for the PreciseBreast test. You can also contact our billing department at 855-212-4410.
The cost of the test will depend on your individual health insurance coverage (for example, in-network, out-of-network, co-insurance, deductible and co-pay). We also offer a Self-Pay program.
Yes, we offer several payment plan options, as well as an interest-free payment plan over a period of up to 6 months.
Yes, please contact our billing team to further discuss our Patient Assistance Program (PAP) and eligibility requirements. A copy of our PAP application can be found at precisedx.ai
Please call our billing department at 855-212-4410 to arrange for payments. Diagnostic laboratory tests are also eligible for reimbursement with a Flexible Spending Account (FSA) or a Health Savings Account (HSA). We accept all major credit cards, checks and money orders.
1. Endorse the check by signing the back and writing the following under your signature: “Payable to PreciseDx, Inc.” 2. Please mail the check along with any cost-sharing, deductible or co-pay amounts and a copy of the Explanation of Benefits (EOB) to the following address: PreciseDx, Inc. P.O. Box 25532 New York, NY 10087- 5536 Please contact our Billing Team if you have any questions or concerns at 855-212-4410
Contact us today to learn more about PreciseBreast.
